Paravertebral Catheter for Lung Transplant

• Status: Completed
• Trial end date: 2014-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a prospective observational trial of patient undergoing lung transplantation who have a thoracic paravertebral catheter(s) placed for postoperative pain control. Patients pain scores and opioid use were evaluated for 7 days after placement as well as any complications, opioid adverse events, and length of stay.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Minnesota; University of Minnesota - Clinical and Translational Science Institute
• Treatments: Ropivacaine

Criteria

Inclusion Criteria:

• lung transplant

• clamshell incision

• received paravertebral catheter within 2 days of surgery

Exclusion Criteria:

• non english speaking

• remained intubated for greater than 3 days postoperatively

• midline incision

• allergy to local anesthetics